Co-Leader WG5
Dr Thomas Hammond (thomas.Hammond@unibas.ch)
Molecular and Systems Toxicology, University of Basel (Switzerland)
| Higher Education | |
|---|---|
| 2008-2012 | Phd in Toxicology, University of Liverpool. CASE Sponsorship from AstraZeneca Thesis Title: In Vitro and in Vivo Investigation into the Interactions between then Acyl Glucoronide Metabolite of Diclofenac and Serum Albumin |
| 2007-2008 | MRed (Distinction) in Biomedical Sciences, University of Liverpool |
| 2003-2006 | BSc (2.1, Hons) in Pharmacology, University of Newcastle-upon-Tyne |
| Work Experience | |
|---|---|
| 2014-Present | Postdoctoral Research Fellow, Division of Molecular and Systems Toxicology, University of Basel, Switzerland |
| 2013-2014 | Postdoctoral Research Asociate, Division of Molecular and Systems Toxicology, University of Basel, Switzerland |
| 2007-2008 | Graduate Pharmacologist, Ferring Research, Chilworth, Southampton, UK |
| Honorary Positions | |
|---|---|
| 2014-Present | Leader Panel for Bioanalysis Zone |
| 2013-Present | Ambassador for the British Toxicology Society |
| 2016 | Organizing Committe for the Swiss Society of Toxicology Annual Meeting |